Lv5
1440 积分 2022-10-17 加入
Asciminib (ASC) in chronic myeloid leukemia in chronic Phase (CML-CP): Interim analysis (IA) efficacy and safety results of the Phase 2 ASC2ESCALATE trial in the cohort of newly diagnosed (1L) patients (pts)
15天前
已关闭
Thrombopoietin receptor agonists for marrow failure: A concise clinical review
1个月前
已完结
Application of thrombopoietic agents in cancer therapy-induced thrombocytopenia: A comprehensive review
1个月前
已完结
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
1个月前
已完结
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
1个月前
已完结
Treatment Outcomes in Chronic Myeloid Leukemia: Does One Size Fit All?
1个月前
已关闭
Mental Health Disorders among Hodgkin Lymphoma Survivors in a Population-based Cohort Study
1个月前
已完结
Re: Devic et al. (Int J Radiat Oncol Biol Phys 2010;78:1555–1562)
1个月前
已关闭
Risk of diabetes mellitus in long-term survivors of Hodgkin lymphoma
1个月前
已关闭
Risk of diabetes mellitus in long-term survivors of Hodgkin lymphoma
1个月前
已关闭
皖公网安备34019202002308
